HTRA1 and cancer: A retrospective study of 333 nonmetastatic patients with locally advanced BC who underwent neoadjuvant chemotherapy (NACT) showed that high HTRA1 expression may indicate a lack of response to NACT and a predictor of increased risk of cancer recurrence and death [56].